account_balance
Investment manager · 13F filer · SEC CIK 1637359
Omega Fund Management, LLC
Reported value$186Mas of Jun 30, 2026
Positions10 1 new, 1 sold out
Top 10 weight100%BCAX alone is 29%
FiledAug 1445 days after quarter end
Portfolio · as of Jun 30, 2026
Where the money is
New or addedTrimmedHeld
BCAX
Bicara Therapeutics Inc.
29.1%Trimmed
NUVB
Nuvation Bio Inc.
24.7%
KMTS
Kestra Med Technologies Ltd
14.0%
BBOT
BridgeBio Oncology Therapeutics Inc.
13.5%
BBNX
Beta Bionics Inc.
11.1%
ALMS
Alumis Inc.
3.7%
SANA
Sana Biotechnology, Inc.
1.6%
IMA
ImageneBio, Inc.
1.4%
enGene Holdings Inc.
0.8%
ODTX
0.0%
Box size is the share of the fund's reported holdings. 13F only covers US-listed stocks, so foreign holdings and short positions are missing.
What changed